Biotech Investor Sentiment Climbing Steadily, with Growing Enthusiasm Heading into 2025 Posted on November 9, 2024November 9, 2024 by admin The sector’s XBI is up 15% year-to-date; rate cuts, election outcome, and M&A are viewed as tailwinds.
